Drug Name:
ASTEPRO 0.15% Rx
Generic Name and Formulations:
Azelastine HCl 0.15% (205.5mcg/spray;) aqueous nasal spray; contains benzalkonium chloride.
Company:
Meda Pharmaceuticals
Therapeutic Use:
Indications for ASTEPRO 0.15%:
Seasonal and perennial allergic rhinitis.
Adult:
Seasonal: 1 or 2 sprays in each nostril twice daily or 2 sprays in each nostril once daily. Perennial: 2 sprays in each nostril twice daily.
Children:
Not recommended.
Warnings/Precautions:
Avoid eyes, mouth. Pregnancy (Cat.C). Nursing mothers.
Interactions:
Potentiates CNS depression with alcohol, other CNS depressants. Caution with other antihistamines.
Pharmacological Class:
Antihistamine.
Adverse Reactions:
Bitter taste, nasal discomfort, epistaxis, headache, fatigue, somnolence, sneezing.
How Supplied:
Spray—17mL (106 sprays), 30mL (200 sprays)
Endocrinology Advisor Articles
- Clinicians May Be Overtreating Older Patients With Diabetes
- Obesity Risk in Infants Born to Women With Diabetes
- Increased Risk for Mortality in People With Diabetes, CHD Taking Beta-Blockers
- Autism Does Not Affect Metabolic Control in Type 1 Diabetes
- Prediabetes a Useful Indicator for Cardiovascular and Renal Risks
Sign Up for Free e-Newsletters
Check out what's trending
CME Focus
Contemporary Management of Type 2 Diabetes
CME
1.00 Credits